Bank of New York Mellon Corp - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 95 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$892,000
-54.7%
184,334
-0.4%
0.00%
-100.0%
Q4 2019$1,967,000
+3.4%
185,080
+1.2%
0.00%0.0%
Q3 2019$1,903,000
-23.4%
182,808
+12.8%
0.00%0.0%
Q2 2019$2,483,000
+12.8%
162,048
-5.3%
0.00%0.0%
Q1 2019$2,201,000
+71.8%
171,202
+27.0%
0.00%
Q4 2018$1,281,000
-27.6%
134,756
+26.5%
0.00%
Q3 2018$1,769,000
+6.2%
106,558
+2.7%
0.00%
Q2 2018$1,666,000
-4.1%
103,806
-8.6%
0.00%
Q1 2018$1,737,000
+10.4%
113,578
+12.7%
0.00%
Q4 2017$1,573,000
+73.0%
100,813
+23.1%
0.00%
Q3 2017$909,000
+14.5%
81,914
-5.0%
0.00%
Q2 2017$794,000
+6.6%
86,196
-1.0%
0.00%
Q1 2017$745,000
+8.8%
87,091
+36.0%
0.00%
Q4 2016$685,000
+27.1%
64,014
+28.7%
0.00%
Q3 2016$539,000
+52.7%
49,733
-4.6%
0.00%
Q2 2016$353,000
+39.0%
52,108
-4.5%
0.00%
Q1 2016$254,000
-25.9%
54,546
+0.6%
0.00%
Q4 2015$343,000
-28.8%
54,231
-0.5%
0.00%
Q3 2015$482,000
-45.0%
54,516
-26.7%
0.00%
Q2 2015$876,000
-23.6%
74,420
-6.1%
0.00%
Q1 2015$1,147,000
+23.1%
79,263
+45.2%
0.00%
Q4 2014$932,000
+52.8%
54,601
+11.4%
0.00%
Q3 2014$610,000
-57.5%
49,002
-49.8%
0.00%
Q2 2014$1,434,000
+74.9%
97,664
+142.3%
0.00%
Q1 2014$820,000
+1.9%
40,311
-1.8%
0.00%
Q4 2013$805,000
-79.2%
41,069
-51.9%
0.00%
-100.0%
Q3 2013$3,868,000
+357.2%
85,436
+140.8%
0.00%
Q2 2013$846,00035,4860.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
QVT Financial LP 220,000$9,965,0000.68%
Healthcare Value Capital, LLC 16,464$746,0000.65%
EAM Investors, LLC 69,151$3,132,0000.62%
Baker Brothers Advisors 800,400$36,255,0000.52%
Spark Investment Management LLC 38,300$1,733,0000.40%
Perceptive Advisors 180,416$8,172,0000.34%
SIGMA CAPITAL MANAGEMENT LLC 175,000$7,926,0000.33%
DRIEHAUS CAPITAL MANAGEMENT LLC 129,915$5,885,0000.23%
Visium Asset Management, LP 150,000$6,794,0000.15%
ESSEX INVESTMENT MANAGEMENT CO LLC 19,732$894,0000.14%
View complete list of STEMLINE THERAPEUTICS INC shareholders